BEAUTYFARM MED2373.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, BEAUTYFARM MED (2373.HK) trades at a P/E of 9.72x, P/B of 2.64x, P/S of 1.09x, and a dividend yield of 4.24%.
Longitudinal percentile comparison: P/E sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/B sits at the 1st percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/S sits at the 4th percentile over the trailing 10Y window (vs. 5th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 47th percentile within its industry and the 44th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 6.09%, ranking at the 100th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 0.5 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 4.24% comes from cash dividends, with an implied ~1.85% from buybacks — a fairly balanced mix of both channels. BEAUTYFARM MED operates in the Exclusive Chain sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 2373 · SEHK: 2373 · 2373
Want the full picture on whether BEAUTYFARM MED (2373.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 9.72 | ||||||
| P/B (MRQ) | 2.64 | ||||||
| P/S (TTM) | 1.09 | ||||||
| Dividend Yield | 4.24% | ||||||
| Buyback + Div Yield | 6.09% |